Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Rash in SLE patients indicates more severe disease.

Multiple plasma donations do not change donors' biochemical parameters.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Celtis choseniana may help treat hair loss by reducing androgen effects and boosting hair growth signals.

Plant surfactants from quinoa and soybeans are effective, safe, and eco-friendly for shampoos.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Higher IL-21 levels may help predict alopecia areata activity.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

Low serum ferritin levels are linked to hair loss in women.

Balding and low testosterone increase risk of urinary stones.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Higher apelin-12 levels may indicate more severe acne.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Sensitive scalp has higher pH, more redness, abnormal sebum, and altered bacterial makeup.

Lower vitamin D levels are linked to more severe hair loss in men.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Low iron levels may be linked to some types of hair loss in women.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Low iron and vitamin D levels are linked to hair loss in women.

FA2H is essential for normal fur and sebum production in mice.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.